Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
40 /100
MEDIUM RISK
Score updated Sep 12, 2026

SXTC — China SXT Pharmaceuticals, Inc. Dilution Risk Tracker

Track SXTC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SXTC — Get alerts when the score changes →

As of September 12, 2026, China SXT Pharmaceuticals, Inc. (SXTC) has a DilutionWatch DilutionScore of 40/100, rated MEDIUM dilution risk. China SXT Pharmaceuticals, Inc. has a market capitalization of $7.44M, 958.1K shares outstanding, 8 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $760.0K.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
37
💰 Cash Runway
0
📊 Float Risk
55
⚠️ Warrant Exposure
40
🔄 Convertible Debt
60

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 32%
🔁 Convertible Conversion model 40%
• Significant convertible debt: 21% potential dilution
• Elevated convertible risk (60/100)
🔄 Reverse Split model est. 30%
• 50-day avg $1.80 approaching $1 threshold
💰 Capital Raise model 18%
• Active ATM program with $1M remaining capacity
🔔 Track SXTC — Get forecast alerts →

Market Data

Market Cap$7.44M
Shares Outstanding958.1K
Float740.8K
Cash$28.18M
Debt$648.9K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore40/100DilutionWatch score record
Shares Outstanding958.1KVerified float table or market cache
Public Float740.8KVerified float table or market cache
Market Cap$7.44MMarket data cache
Cash Runway84.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$760.0KSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 4.

Recent SEC source mix: 424B5 1, 6-K 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 5.4% shares (2025Q4 vs prior)
8 institutional holders · 327.6K shares
#1 CITADEL ADVISORS LLC 150.6K shares
#2 Invesco Ltd. 85.3K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 53.7K shares
+ 5 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest18.6K
Days to Cover1.0
% of Float2.5%
FINRA data as of Aug 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-03-31
xbrl XBRL WARRANT 2023-09-30
424B5 ATM 2026-04-09
6-K 8K EVENT 2026-04-09
Full SEC filing analysis available with free account

Recent News

No recent news

Factual SXTC Dilution Snapshot

China SXT Pharmaceuticals, Inc. (SXTC) has a DilutionScore of 40/100, rated Medium dilution risk. Score date: September 12, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track SXTC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SXTC — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,348+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for SXTC
SXTC FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.